Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Cerulean Pharma Inc. to Convene Nanomedicine Pioneers at 2010 American Chemical Society (ACS) National Meeting & Exposition in Boston

Abstract:
ACS Symposium Will Examine Nanotechnology's Potential Impact on Developing Improved Therapies and Diagnostics to Address a Broad Range of Diseases

Cerulean Pharma Inc. to Convene Nanomedicine Pioneers at 2010 American Chemical Society (ACS) National Meeting & Exposition in Boston

Cambridge, MA | Posted on August 19th, 2010

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced it will assemble a group of leading scientific experts at the American Chemical Society's ("ACS") 240th National Meeting & Exposition for a three-day thought leadership summit on the advancement of nanotechnology in the pharmaceutical and diagnostic industries. ACS, which bills itself as the world's largest scientific society, will host its national meeting from August 22 through August 26 at the Boston Convention and Exhibition Center in Boston, Massachusetts.

The inaugural symposium, titled "Multifunctional Nanoparticles for Drug Delivery and Imaging," will feature close to 60 oral and poster presentations from renowned U.S. and international researchers. Key themes will include diagnostic imaging, experimental therapy, and drug delivery technologies for therapeutic agents ranging from small molecules and peptides, to new classes of therapies such as siRNA.

"Nanotechnology has the potential to revolutionize medicine by improving the safety, efficacy, and bioavailability of therapies," said Robert S. Langer, Ph.D., David H. Koch Institute Professor at the Massachusetts Institute of Technology and a keynote speaker at the nanotechnology summit. "An ACS National Meeting symposium, focused on the key role nanotechnology will play in the future of medicine, represents significant validation for this exciting research area."

Dr. Langer will deliver his keynote address on Sunday, August 22, highlighting the most promising potential applications of nanotechnology in medicine. A second keynote address will be delivered on Monday, August 23, by Piotr Grodzinski, Ph.D., Director of the National Cancer Institute (NCI) Alliance for Nanotechnology in Cancer, which will focus on the latest development in nanotechnology-based cancer therapy.

"ACS is a premier global scientific organization whose decision to highlight nanotechnology in medicine lends significant credibility to this emerging field," said Oliver Fetzer, Ph.D., President and Chief Executive Officer of Cerulean.

"We are excited to convene leading scientific experts who are shaping the future of this promising research area," added John Ryan, Ph.D., M.D., Cerulean's Chief Medical Officer. "Cerulean is committed to continuing its leadership position in nanopharmaceuticals by advancing its clinical and pre-clinical programs, and by creating opportunities for thought leaders to gather and discuss new discoveries and advances in the technology."

At the symposium, Dr. Ryan will be presenting data on CRLX101 (formerly IT-101), Cerulean's clinical nanopharmaceutical drug candidate in Phase 2a development. Company scientists will also be presenting data on CRLX288, one of Cerulean's pre-clinical development candidates, details of which will be revealed for the first time at this symposium.

Copies of Cerulean's oral and poster presentation abstracts are available at abstracts.acs.org/chem/240nm/program/divisionindex.php by searching the term "Cerulean"

####

About Cerulean Pharma
Cerulean Pharma Inc. is a clinical-stage company specializing in the design and development of nanopharmaceuticals optimized to make drugs more effective and with fewer side effects. Cerulean is applying its proprietary nanopharmaceutical platform technologies and specialized capabilities to advance a new class of therapeutic agents for diseases with unmet medical needs. With an initial focus in oncology, the Company's technology platform can be readily applied to a wide range of drug molecules, ranging from small molecules to peptides and RNAs. Cerulean is privately financed and funded by experienced healthcare investors, including Polaris Venture Partners, Venrock, Lux Capital, Bessemer Venture Partners, and William H. Rastetter. Cerulean is located in Cambridge, Massachusetts.

For more information, please click here

Contacts:
Schwartz Communications
Andrew Law/Benjamin Navon
+1 781-684-0770

Copyright © Business Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Oregon researchers glimpse pathway of sunlight to electricity: Collaboration with Lund University uses modified UO spectroscopy equipment to study 'maze' of connections in photoactive quantum dots December 19th, 2014

Instant-start computers possible with new breakthrough December 19th, 2014

Aculon Hires New Business Development Director December 19th, 2014

Iranian Scientists Use Nanotechnology to Increase Power, Energy of Supercapacitors December 18th, 2014

Possible Futures

A novel method for identifying the body’s ‘noisiest’ networks November 19th, 2014

Researchers discern the shapes of high-order Brownian motions November 17th, 2014

VDMA Electronics Production Equipment: Growth track for 2014 and 2015 confirmed: Business climate survey shows robust industry sector November 14th, 2014

Open Materials Development Will Be Key for HP's Success in 3D Printing: HP can make a big splash in 3D printing, but it needs to shore up technology claims and avoid the temptation of the razor/razor blade business model in order to flourish November 11th, 2014

Nanomedicine

Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014

Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014

Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial December 17th, 2014

Unraveling the light of fireflies December 17th, 2014

Announcements

Oregon researchers glimpse pathway of sunlight to electricity: Collaboration with Lund University uses modified UO spectroscopy equipment to study 'maze' of connections in photoactive quantum dots December 19th, 2014

Instant-start computers possible with new breakthrough December 19th, 2014

Aculon Hires New Business Development Director December 19th, 2014

Iranian Scientists Use Nanotechnology to Increase Power, Energy of Supercapacitors December 18th, 2014

Events/Classes

Bruker Introduces BioScope Resolve High-Resolution BioAFM System: Featuring PeakForce Tapping for Quantitative Bio-Mechanical Property Mapping December 16th, 2014

TCL Launches World’s Most Advanced TV in the World’s Largest Market: New Quantum Dot TVs with Color IQ™ Optics Deliver OLED-Quality Color at a Fraction of the Price December 15th, 2014

Stanford team combines logic, memory to build a 'high-rise' chip: Today circuit cards are laid out like single-story towns; Futuristic architecture builds layers of logic and memory into skyscraper chips that would be smaller, faster, cheaper -- and taller December 15th, 2014

PETA science consortium to present at Society for Risk Analysis meeting December 10th, 2014

Nanobiotechnology

Scientists trace nanoparticles from plants to caterpillars: Rice University study examines how nanoparticles behave in food chain December 16th, 2014

FEI and Oregon Health & Science University Install a Complete Correlative Microscopy Workflow in Newly Built Collaborative Science Facility December 16th, 2014

UCLA engineers first to detect and measure individual DNA molecules using smartphone microscope December 15th, 2014

Biomimetic dew harvesters: Understanding how a desert beetle harvests water from dew could improve drinking water collection in dew condensers December 8th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE